Anagenics Ltd has released a press release.
New Publication for Cellmids Midkine Antibody
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Anagenics
- Transcript of Cellmid Investor Briefing Call
- CDY: Ikon Legal Action
- USA Distribution Partnership for Cellmids Evolis
- MK antibody publication and patent in bone healing
- Midkine Strategy Update
Later from Anagenics
- European Midkine Patent For Surgical Adhesion Allowed
- Midkine Antibodies Show Anti-Tumor Activity In Brain Cancer
- Cellmid records highest ever quarterly sales for evolis
- ASX Market Release - Reinstatement
- Cellmid: Appendix 3Y- Change of Director’s Interest Notice
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics